UK telehealth platform pricing in 2026: what you should pay, what is worth paying for

UK telehealth platform pricing in 2026 falls into four common structures: monthly platform fees, per-dispense fees, revenue share, and hybrid models. Some of those align with the operator's incentives. Some do not. This piece walks through what each model actually charges, what it includes, and where PExpo sits — so you can compare across vendors without getting lost in opaque pricing pages.

The four pricing structures in UK telehealth platforms

Monthly platform fees — a flat subscription, typically £500-5,000 per month depending on volume and features. Per-dispense fees — a charge per dispensed prescription, typically £2-15 depending on category and SLA. Revenue share — a percentage of patient revenue, typically 10-30%. Hybrid — a combination of platform fee plus per-dispense or rev share. Each structure has different alignment between platform and operator, and the right one depends on operator stage and category.

Monthly platform fees — what they should include

A monthly platform fee should include access to the platform, clinical workflow, support tooling, and basic integrations. It should not include the dispensing — that is typically priced separately. Watch for platform fees that do not include the clinical layer, or that meter API calls separately on top. The clearer the fee scope, the easier the comparison across vendors.

Per-dispense fees — the line items that matter

Per-dispense fees should be transparent and itemised. The components: pharmacist sign-off, picking and packing, courier handling, exception handling, basic patient support relating to the dispense, and pharmacovigilance capture. Cold-chain dispensing typically commands a premium. Same-day dispatch typically commands a premium. Operators should see each line, not a single blended number.

Revenue share — when it works and when it does not

Revenue share aligns platform and operator on growth — both benefit when the brand grows. It misaligns on margin — the platform takes the same share whether the patient is profitable or marginal. Revenue share suits early-stage operators with limited cashflow and works less well as the brand matures and unit economics matter more. Most maturing brands transition off revenue share by year two or three.

PExpo's pricing — £0 platform fee, transparent per-request

PExpo's clinic model is £0 platform fees with a transparent admin client care fee per request. The brand model is configured per-brand based on category mix and volume — typically a per-dispense fee aligned with the operator's unit economics rather than revenue share. See our pricing page for current rates, our clinic model page for the clinic scope, and our brand model page for the white-label brand option.

What to compare on a like-for-like basis

When comparing vendors, normalise to per-dispense effective cost. Take any monthly platform fee, divide by your monthly dispense volume, add the per-dispense fee. That gives a like-for-like number across pricing structures. Then check what is included at that price — clinical workflow, prescriber network, dispensing, integrations. A 'cheap' vendor that does not include clinicians is often more expensive than a higher-priced vendor that does.

Normalise vendor pricing to per-dispense effective cost. A 'cheap' vendor that doesn't include clinicians is often more expensive than a higher-priced vendor that does.

UK telehealth platform pricing in 2026 is comparable if you normalise structures to per-dispense effective cost and check what is included at that price. The vendors worth paying for are the ones that include the load-bearing layers — clinical workflow, prescribers, dispensing — at a transparent line-item price. See our pricing page for PExpo's current rates, our clinic model page for the £0 platform fee clinic setup, and our brand model page for the white-label brand option.

Frequently asked questions